As we celebrate summer and all that is blooming, we look back at seeds planted through our Seed Grant Program, and are optimistic about the progress being made in pancreatic […]
New research on enzyme MMP-7 holds potential for drug development
As we celebrate spring and the blooms to come, we are looking back at seeds planted through our Seed Grant Program, and are optimistic about the progress being made in […]
Understanding Early Tumor Progression Through Tuft Cells
One of the main ways to improve the outcomes for pancreatic cancer patients is early diagnosis and the way to better diagnostics is through a greater understanding of the initiating […]
UCLA Researchers Receive Over $6M from NIH to Study Potential Immunotherapies for Pancreatic Cancer
Research teams at UCLA have received two grants from the National Institutes of Health (NIH), totaling over $6 million dollars to study the immunobiology of pancreatic tumors and develop a […]
Hirshberg funded UCLA study finds combination therapy suppresses pancreatic tumor growth
UCLA Jonsson Comprehensive Cancer Center researchers, including our Scientific Advisory Board member and close collaborator, Dr. Timothy Donahue have uncovered a therapy that subdues tumor growth. The study, published in […]
Research Identifies Loss of Protein Linking Chronic Pancreatitis to Pancreatic Cancer, May Present New Tailored Therapy
Chronic pancreatitis is a known risk factor for the development of pancreatic cancer. However, the genetic alterations that cause this chronic inflammation and therefore predispose the patient to malignant transformation […]